Bdron™ is a quality-assured generic of Zytiga® which is approved to treat prostate cancer. It is used in combination with prednisone for the treatment of metastatic castration-resistant prostate cancer (mCRPC) and metastatic high-risk castration-sensitive prostate cancer (CSPC) in adult men.
Bottle Size : 60 Tablets (500 mg strength)
Active Ingredients: Abiraterone 500 MG
Produced by : BDR Pharmaceuticals Ltd®